Anuh Pharma Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Anuh Pharma has a total shareholder equity of ₹2.9B and total debt of ₹26.9M, which brings its debt-to-equity ratio to 0.9%. Its total assets and total liabilities are ₹4.5B and ₹1.5B respectively. Anuh Pharma's EBIT is ₹636.0M making its interest coverage ratio -80. It has cash and short-term investments of ₹622.6M.
Anahtar bilgiler
0.9%
Borç/özkaynak oranı
₹26.93m
Borç
| Faiz karşılama oranı | -80x |
| Nakit | ₹622.56m |
| Eşitlik | ₹2.91b |
| Toplam yükümlülükler | ₹1.54b |
| Toplam varlıklar | ₹4.46b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 506260's short term assets (₹3.4B) exceed its short term liabilities (₹1.5B).
Uzun Vadeli Yükümlülükler: 506260's short term assets (₹3.4B) exceed its long term liabilities (₹17.7M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 506260 has more cash than its total debt.
Borcun Azaltılması: 506260's debt to equity ratio has reduced from 2.7% to 0.9% over the past 5 years.
Borç Kapsamı: 506260's debt is well covered by operating cash flow (480%).
Faiz Kapsamı: 506260 earns more interest than it pays, so coverage of interest payments is not a concern.